LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Gourmey joins EuropaBio: Pioneering Sustainable Cultivated Meat

14/03/2024

PRESS RELEASE

Brussels, Belgium - 14 March 2024 - EuropaBio, is delighted to announce the newest addition to its membership, France's pioneering cultivated meat company, Gourmey,

Founded in 2019, Gourmey creates sustainable restaurant-grade meats from real animal cells, contributing to new ways of animal protein production while minimising the environmental impact.

While meat consumption is expected to increase by over 70% by 2050, climate change and animal diseases such as bird flu impact agricultural capacity.

To enhance European resilience and competitiveness in the global food supply chain, Gourmey is working to accelerate the world’s transition toward more ethical and sustainable food products. This aligns with EuropaBio's mission to foster innovation, sustainability and progress through biotechnology.

“We are thrilled to welcome Gourmey to EuropaBio,” said Dr. Claire Skentelbery, Director General of EuropaBio. “Pioneering biotechnology companies are emerging to help secure European food production, whilst contributing towards sustainable agriculture. EuropaBio advocates for a faster route to market than Europe currently offers compared to other regions, so that we can fulfill Green Deal objectives and create a competitive future from our own amazing research base. Such companies are the future of European innovation and resilience and need to be recognised as such.”

Nicolas Morin-Forest, CEO and Co-founder at Gourmey said "Our mission is to transform cultivated meat by marrying culinary heritage with cutting-edge innovation—without compromising on quality or safety. Our flagship product, a cultivated version of iconic foie gras, demonstrates how tradition and innovation can coexist.
We're committed to addressing the regulatory, policy and scale-up challenges in the EU to build a resilient and innovative food system in Europe. Biotech food production is a critical technology - and therefore we need to keep it in and for the European Union to support European food sovereignty".

Gourmey joins EuropaBio: Pioneering Sustainable Cultivated Meat


Download
Share
Adrian Lincoln
Adrian Lincoln

Related posts

05/12/2025

Slovenia Biotech Hills joins EuropaBio: Elevating Slovenia’s Biotech Ecosystem in Europe


Read more
03/12/2025

OECD: Boosting biotechnology innovation through agile regulation and finance instruments


Read more
28/11/2025

Bioeconomy strategy sets the right pathway for Europe


Read more

Important links

  • Slovenia Biotech Hills joins EuropaBio: Elevating Slovenia’s Biotech Ecosystem in Europe
  • OECD: Boosting biotechnology innovation through agile regulation and finance instruments

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.